Medicine and Dentistry
Atrial Fibrillation
100%
Patient
78%
Coronary Artery Disease
52%
Atrial Fibrillation Ablation
47%
Maturity Onset Diabetes of the Young
46%
Pulmonary Vein Isolation
44%
Inpatient
35%
Cardiovascular System
31%
Coronary Computed Tomography Angiography
30%
Acute Heart Infarction
29%
Catheter Ablation
29%
Supraventricular Tachycardia
29%
Patient with Type 2 Diabetes
28%
Direct Oral Anticoagulant
27%
Atrioventricular Nodal Reentry Tachycardia
26%
Persistent Atrial Fibrillation
25%
Sinus Rhythm
24%
Hazard Ratio
24%
Anticoagulant Therapy
21%
Ablation
20%
Apoplexy
20%
Follow up
20%
Acute Myeloid Leukemia
18%
Mitral Valve Stenosis
18%
Cardiovascular Risk
18%
Interleukin 1
18%
Radiofrequency Ablation
18%
Renin Angiotensin Aldosterone System
18%
Percutaneous Aortic Valve Replacement
18%
Monotherapy
18%
Cause of Death
15%
Rhythm
15%
Percutaneous Coronary Intervention
15%
Cardiac Dysrhythmia
14%
Tachyarrhythmia
14%
Paroxysmal Atrial Fibrillation
12%
Antiarrhythmic Agent
12%
Heart Left Ventricle Ejection Fraction
12%
Drug-Eluting Stent
11%
Recurrent Disease
11%
Scoring System
11%
Combination Therapy
10%
Myocardial Infarction
10%
All Cause Mortality
10%
Cardiovascular Disease
10%
Coronary Artery Obstruction
10%
Recurrence Risk
10%
Computer Assisted Tomography
9%
Progression of Coronary Artery Disease
9%
Electrocardiogram
9%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
48%
Coronary Artery Disease
31%
Acute Heart Infarction
29%
Non Insulin Dependent Diabetes Mellitus
27%
Atrial Fibrillation
20%
Stent
19%
Cause of Death
18%
Prehypertension
18%
Interleukin 2 Receptor Alpha
18%
Acute Myeloid Leukemia
18%
Direct Oral Anticoagulant
18%
Acute Heart Infarction
18%
Congestive Heart Failure
15%
Monotherapy
15%
Heart Infarction
15%
Heart Failure
14%
Cause of Death
14%
Coronary Artery Disease
13%
Incidence
11%
Indicator
11%
Prognosis
11%
Heart Arrhythmia
11%
Supraventricular Tachycardia
11%
Death
11%
Drug
11%
Coronary Artery Obstruction
10%
Tachycardia
10%
Non Insulin Dependent Diabetes Mellitus
9%
Dipeptidyl Peptidase IV Inhibitor
9%
Antiarrhythmic Agent
9%
Device Infection
9%
Renin
9%
Angiotensin
9%
Heart Arrhythmia
9%
Heart Death
9%
Cardiovascular Risk
9%
Persistent Atrial Fibrillation
9%
Renin
9%
Leporidae
9%
Dipeptidyl Carboxypeptidase
9%
Adhesive Agent
9%
Interleukin 1
9%
Mitral Valve Regurgitation
9%
Chemotherapy
9%
Angiotensin
9%
Dipeptidyl Carboxypeptidase
9%
Autonomic Dysfunction
9%
Paroxysmal Atrial Fibrillation
9%
Persistent Atrial Fibrillation
9%
Acute Myeloid Leukemia
9%